Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation

Explore clinical trials studying Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation trial results

Completed

Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02272790

Conditions: Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
Locations: Research Site Gilbert, Arizona, United States

Research Site Tucson, Arizona, United States

Research Site La Jolla, California, United States

Research Site Los Angeles, California, United States

View all 20 locations

View Trial Details